undamentalytics Newsletter
Sign in

Inspire Medical Systems, Inc. cash flow statement

In fiscal 2025, Inspire Medical Systems, Inc.'s operations generated $117m of cash; it spent $38.5m on capital projects, leaving free cash flow of $78.5m. It returned $175m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations−18−16−19−33−53−201225130117135
Depreciation and amortisation0000112371419
Stock-based pay001613265282116130117
Capital spending000325924393837
Free cash flow−18−16−19−36−56−2521917898
Free cash flow after stock pay−19−16−20−42−68−51−49−81−25−52−19
Share buybacks——————00017550
Shares issued001820125024400——

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: INSP vs VREXATEC vs INSPINSP vs OFIX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inspire Medical Systems, Inc.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inspire Medical Systems, Inc.